Subfoveal Choroidal Neovascularization

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-05-30
Clinical Trial Update: Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization [Phase 2, Phase 3]
A Phase 2/3 comparative trial evaluating photodynamic therapy with triamcinolone versus photodynamic therapy with triamcinolone and ranibizu…
CLINICAL_TRIALS trial_result · 2016-03-04
Clinical Trial Update: Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 4]
Phase 4 safety and tolerability update of ranibizumab in patients with subfoveal choroidal neovascularization secondary to age-related macul…